Table of Contents

company-logo

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.

Ondine Biomedical Dividend Announcement

• Ondine Biomedical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Ondine Biomedical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Ondine Biomedical Dividend History

Ondine Biomedical Dividend Yield

Ondine Biomedical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ondine Biomedical stock? Use our calculator to estimate your expected dividend yield:

Ondine Biomedical Financial Ratios

P/E ratio-2.38
PEG ratio14.29
P/B ratio9.55
ROE-268.46%
Payout ratio0.00%
Current ratio1.36
Quick ratio1.06
Cash Ratio0.85

Ondine Biomedical Dividend FAQ

Does Ondine Biomedical stock pay dividends?
Ondine Biomedical does not currently pay dividends to its shareholders.
Has Ondine Biomedical ever paid a dividend?
No, Ondine Biomedical has no a history of paying dividends to its shareholders. Ondine Biomedical is not known for its dividend payments.
Why doesn't Ondine Biomedical pay dividends?
There are several potential reasons why Ondine Biomedical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ondine Biomedical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ondine Biomedical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ondine Biomedical a dividend aristocrat?
Ondine Biomedical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ondine Biomedical a dividend king?
Ondine Biomedical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ondine Biomedical a dividend stock?
No, Ondine Biomedical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ondine Biomedical stocks?
To buy Ondine Biomedical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ondine Biomedical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.